Characterization of the Outer Domain of the gp120 Glycoprotein from Human Immunodeficiency Virus Type 1
- 1 December 2004
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (23) , 12975-86
- https://doi.org/10.1128/jvi.78.23.12975-12986.2004
Abstract
The core of the gp120 glycoprotein from human immunodeficiency virus type 1 (HIV-1) is comprised of three major structural domains: the outer domain, the inner domain, and the bridging sheet. The outer domain is exposed on the HIV-1 envelope glycoprotein trimer and contains binding surfaces for neutralizing antibodies such as 2G12, immunoglobulin G1b12, and anti-V3 antibodies. We expressed the outer domain of HIV-1(YU2) gp120 as an independent protein, termed OD1. OD1 efficiently bound 2G12 and a large number of anti-V3 antibodies, indicating its structural integrity. Immunochemical studies with OD1 indicated that antibody responses against the outer domain of the HIV-1 gp120 envelope glycoprotein are rare in HIV-1-infected human sera that potently neutralize the virus. Surprisingly, such outer-domain-directed antibody responses are commonly elicited by immunization with recombinant monomeric gp120. Immunization with soluble, stabilized HIV-1 envelope glycoprotein trimers elicited antibody responses that more closely resembled those in the sera of HIV-1-infected individuals. These results underscore the qualitatively different humoral immune responses elicited during natural infection and after gp120 vaccination and help to explain the failure of gp120 as an effective vaccine.Keywords
This publication has 115 references indexed in Scilit:
- Promoting Trimerization of Soluble Human Immunodeficiency Virus Type 1 (HIV-1) Env through the Use of HIV-1/Simian Immunodeficiency Virus ChimerasJournal of Virology, 2004
- HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sitesNature, 2002
- High Levels of Antibodies to the CD4 Binding Domain of Human Immunodeficiency Virus Type 1 Glycoprotein 120 Are Associated with Faster Disease ProgressionThe Journal of Infectious Diseases, 2002
- Solid-Phase Proteoliposomes Containing Human Immunodeficiency Virus Envelope GlycoproteinsJournal of Virology, 2002
- Purification and Characterization of Oligomeric Envelope Glycoprotein from a Primary R5 Subtype B Human Immunodeficiency VirusJournal of Virology, 2002
- Comparison of Two Different Preparations of HIV Immune Globulin for Efficiency of Neutralization of HIV Type 1 Primary IsolatesAIDS Research and Human Retroviruses, 2002
- Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteersAIDS, 1998
- Preparation and Characterization of Human HIV Type 1 Neutralizing Reference SeraAIDS Research and Human Retroviruses, 1995
- Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptidesImmunity, 1994
- Cross-Neutralizing Antibodies in Rabbits Immunized with HIV-1 gp160 Purified from Simian Cells Infected with a Recombinant Vaccinia VirusAIDS Research and Human Retroviruses, 1991